In pT2‐4 cancers, PTEN deletions were unrelated to established parameters of tumor aggressiveness including pT, pN, lymphatic and venous invasion (Table 2) as well as to patient overall survival (p > 0.5; Figure 2). This evidence concerns the gene PTEN and cancer.